Voltage-dependent sodium channels — Drug Target
All drugs that target Voltage-dependent sodium channels — marketed and clinical-stage. Includes 2 drug classes acting on this target.
Drug classes
Anticonvulsant · Anticonvulsants
Phase 3 pipeline (2)
- topiramate, phenytoin · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. · Anticonvulsant · Neurology
Topiramate is an anticonvulsant that works by blocking voltage-dependent sodium channels, stabilizing neuronal membranes, and reducing the release of excitatory neurotransmitters. - Topiramate; Carbamazepine; Valproate · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. · Anticonvulsants · Neurology
Topiramate is an anticonvulsant that acts as a voltage-dependent sodium channel blocker, whereas Carbamazepine is a tricyclic compound that stabilizes inactivated sodium channels, and Valproate is a fatty acid with anticonvulsant properties.